FDANot Yet Classified · Drug · Recalled July 8, 2026

Glucagon Emergency Kit for Low Blood Sugar recall — Lupin Pharmaceuticals Inc.

Hazard: CGMP deviation: OOS result observed for the Gliding Force functionality test during 12-month long term stability testing.

View the official FDA enforcement record (openFDA) ↗

Official recall ID: Not yet assigned by the FDA — identified by FDA event ID 99296
Brand: Lupin Pharmaceuticals
Classification: Not Yet Classified
Units affected: 64,894 units
Recall status: Ongoing
Initiated: Voluntary: Firm initiated

Description

Glucagon Emergency Kit for Low Blood Sugar, Glucagon for Injection USP, 1mg per vial, Diluent for Glucagon, 1 mL syringe, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Naples, FL 34108, Manufactured by: Lupin Limited, Nagpur - 441108, INDIA, NDC 70748-311-01

Affected products

Glucagon Emergency Kit for Low Blood Sugar

Companies & origin

Recalling firm location: Naples, FL, United States
Firm address: 5801 Pelican Bay Blvd Ste 500, N/A, 34108-2734

Identifying details (verbatim from the notice)

Product codes / lots: Kit Lots: WB00010, Exp. Date Jan 2027; WB00017, WB00019, Exp. Date Feb 2027; WB00070, Exp. Date Jun 2027; WB00077, WB00078, Exp. Date Jul 2027; WB00130, Exp. Date Nov 2027.
Distribution: Nationwide within the U.S.
Firm notified the public via: E-Mail
FDA event ID: 99296
Recall initiated: June 23, 2026
FDA report date: July 8, 2026

Source: U.S. Food & Drug Administration. This page mirrors the official public-domain record verbatim; the linked government source is authoritative. Source last checked July 24, 2026 at 3:00 AM UTC.

Report a data error on this page